Wygrecka M - Search Results

1

Biomarkers in idiopathic pulmonary fibrosis.

Drakopanagiotakis F, Wujak L, Wygrecka M, Markart P. Drakopanagiotakis F, et al. Among authors: wygrecka m. Matrix Biol. 2018 Aug;68-69:404-421. doi: 10.1016/j.matbio.2018.01.023. Epub 2018 Jan 31. Matrix Biol. 2018. PMID: 29408012 Review.

2

Evaluation of the In Vitro and In Vivo Effects of Biglycan in Innate Immunity.

Zeng-Brouwers J, Huber LS, Merline R, Trebicka J, Wygrecka M, Schaefer L. Zeng-Brouwers J, et al. Among authors: wygrecka m. Methods Mol Biol. 2023;2619:109-124. doi: 10.1007/978-1-0716-2946-8_9. Methods Mol Biol. 2023. PMID: 36662466

3

Compartment- and cell-specific expression of coagulation and fibrinolysis factors in the murine lung undergoing inhalational versus intravenous endotoxin application.

Wygrecka M, Markart P, Ruppert C, Kuchenbuch T, Fink L, Bohle RM, Grimminger F, Seeger W, Günther A. Wygrecka M, et al. Thromb Haemost. 2004 Sep;92(3):529-40. doi: 10.1160/TH04-02-0126. Thromb Haemost. 2004. PMID: 15351849

4

Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias.

Markart P, Ruppert C, Wygrecka M, Schmidt R, Korfei M, Harbach H, Theruvath I, Pison U, Seeger W, Guenther A, Witt H. Markart P, et al. Among authors: wygrecka m. Eur Respir J. 2007 Jan;29(1):134-7. doi: 10.1183/09031936.00034406. Epub 2006 Sep 27. Eur Respir J. 2007. PMID: 17005585 Free article.

5

Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.

Markart P, Ruppert C, Wygrecka M, Colaris T, Dahal B, Walmrath D, Harbach H, Wilhelm J, Seeger W, Schmidt R, Guenther A. Markart P, et al. Among authors: wygrecka m. Thorax. 2007 Jul;62(7):588-94. doi: 10.1136/thx.2006.062398. Epub 2007 Feb 7. Thorax. 2007. PMID: 17287298 Free PMC article. Clinical Trial.

6

Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs.

Wygrecka M, Markart P, Ruppert C, Petri K, Preissner KT, Seeger W, Guenther A. Wygrecka M, et al. Eur Respir J. 2007 Jun;29(6):1105-14. doi: 10.1183/09031936.00097306. Epub 2007 Mar 1. Eur Respir J. 2007. PMID: 17331968 Free article.

7

Raised protein levels and altered cellular expression of factor VII activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS).

Wygrecka M, Markart P, Fink L, Guenther A, Preissner KT. Wygrecka M, et al. Thorax. 2007 Oct;62(10):880-8. doi: 10.1136/thx.2006.069658. Epub 2007 May 4. Thorax. 2007. PMID: 17483138 Free PMC article.

8

Plasminogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute respiratory distress syndrome.

Wygrecka M, Morty RE, Markart P, Kanse SM, Andreasen PA, Wind T, Guenther A, Preissner KT. Wygrecka M, et al. J Biol Chem. 2007 Jul 27;282(30):21671-82. doi: 10.1074/jbc.M610748200. Epub 2007 May 31. J Biol Chem. 2007. PMID: 17540775 Free PMC article.

9

Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration.

Schmidt R, Markart P, Ruppert C, Wygrecka M, Kuchenbuch T, Walmrath D, Seeger W, Guenther A. Schmidt R, et al. Among authors: wygrecka m. Respir Res. 2007 Jul 27;8(1):55. doi: 10.1186/1465-9921-8-55. Respir Res. 2007. PMID: 17662121 Free PMC article.

10

Role of coagulation and fibrinolysis in lung and renal fibrosis.

Ruppert C, Markart P, Wygrecka M, Preissner KT, Günther A. Ruppert C, et al. Among authors: wygrecka m. Hamostaseologie. 2008 Feb;28(1-2):30-2, 34-6. Hamostaseologie. 2008. PMID: 18278159 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters